Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antitumor combinations containing antibodies recognizing specifically CD38 and vincristine

Antitumor combinations containing antibodies recognizing specifically CD38 and vincristine

US Patent 8633301 · Granted Jan 21, 2014

Estimated economic value: $15,654,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antitumors combinations containing antibodies recognizing specifically CD38 and 2016
Antitumor combinations containing antibodies recognizing specifically CD38 and m2016
Antitumor combinations containing antibodies recognizing specifically CD38 and m2016
Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivativ2013
Combination comprising combretastatin and anticancer agents2010
Use of a taxoid to treat abnormal cell proliferation in the brain2002
Compositions containing at least one farnesyl transferase inhibitor and at least2002